| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.84B | 2.74B | 2.77B | 2.59B | 2.43B |
| Gross Profit | 1.01B | 1.04B | 1.02B | 885.53M | 837.98M |
| EBITDA | 491.56M | 531.41M | 509.37M | 435.40M | 404.83M |
| Net Income | 226.77M | 264.84M | 205.28M | 223.75M | 235.11M |
Balance Sheet | |||||
| Total Assets | 4.77B | 4.03B | 3.83B | 3.75B | 3.46B |
| Cash, Cash Equivalents and Short-Term Investments | 185.86M | 249.36M | 102.00M | 72.02M | 41.21M |
| Total Debt | 1.43B | 1.16B | 1.12B | 1.31B | 109.24M |
| Total Liabilities | 2.55B | 2.23B | 2.18B | 2.37B | 959.53M |
| Stockholders Equity | 2.17B | 1.77B | 1.61B | 1.35B | 2.46B |
Cash Flow | |||||
| Free Cash Flow | 213.28M | 303.62M | 282.32M | 174.12M | 215.15M |
| Operating Cash Flow | 260.57M | 355.40M | 330.49M | 214.36M | 250.74M |
| Investing Cash Flow | -479.88M | -205.70M | -62.24M | -184.42M | -35.27M |
| Financing Cash Flow | 113.70M | 31.67M | -219.72M | 7.56M | -221.57M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $12.27B | 16.84 | 27.46% | 0.85% | 15.71% | 29.60% | |
78 Outperform | $3.70B | 19.10 | 26.34% | 0.67% | 1.55% | 701.41% | |
78 Outperform | $18.63B | 37.45 | 22.99% | 0.24% | 2.40% | 81.54% | |
70 Outperform | $2.39B | 24.74 | 11.16% | 1.27% | 7.43% | 148.83% | |
69 Neutral | $20.20B | 39.98 | 22.69% | ― | 7.75% | 6.84% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | $5.97B | 45.18 | 10.98% | 0.33% | 1.19% | -7.78% |
On March 12, 2026, ESAB Corporation announced it intends to offer $1 billion of senior notes due 2031 in a private placement to qualified institutional buyers in the U.S. and certain investors abroad. The notes will be guaranteed by certain current and future domestic restricted subsidiaries, with the proceeds earmarked to fund a portion of the purchase price for the planned acquisition of Canadian-based Eddyfi Holding Inc., signaling a significant financing step in ESAB’s expansion strategy.
Because the notes are being issued in an unregistered offering under Rule 144A and Regulation S, they will be available only to eligible institutional investors and cannot be freely sold in the U.S. public markets. The transaction underscores ESAB’s continued use of debt markets to support portfolio growth, while leaving completion of both the offering and the acquisition subject to market conditions and customary closing risks that could affect timing and leverage outcomes for stakeholders.
The most recent analyst rating on (ESAB) stock is a Buy with a $120.00 price target. To see the full list of analyst forecasts on ESAB Corporation stock, see the ESAB Stock Forecast page.
On January 31, 2026, ESAB Corporation agreed via a wholly owned subsidiary to acquire Québec-based Eddyfi Holding Inc. and related entities for $1.45 billion in cash, a deal that will make Eddyfi a wholly owned subsidiary and combine ESAB’s fabrication capabilities with Eddyfi’s advanced non-destructive testing, inspection, monitoring and robotics technologies. The acquisition, expected to close in mid-2026 subject to regulatory approvals in multiple jurisdictions, is structured with a $1.0 billion committed bridge loan and $318 million of equity financing and is projected to expand ESAB’s addressable market by about $5 billion, boost its exposure to higher-growth, higher-margin and less cyclical sectors such as aerospace, defense, nuclear, energy and civil infrastructure, and position the company as a full workflow provider from fabrication through inspection and monitoring. To support the financing package, on February 2, 2026 ESAB launched private placements of $175 million of 6.50% Series A Mandatory Convertible Preferred Stock—largely subscribed by entities affiliated with Chairman Mitchell Rales and Steven Rales—and approximately $143 million of common stock to institutional investors, all unregistered offerings under securities law exemptions. ESAB also released preliminary unaudited estimates for the fourth quarter and full year 2025 showing continued revenue and earnings growth, alongside an initial 2026 outlook (excluding Eddyfi) indicating further gains in core revenue, EBITDA and adjusted EPS, while guiding investors to expect a post-transaction net leverage ratio below 3.0x by year-end once the deal closes and synergies begin to materialize.
The most recent analyst rating on (ESAB) stock is a Hold with a $133.00 price target. To see the full list of analyst forecasts on ESAB Corporation stock, see the ESAB Stock Forecast page.